Vimarsana
Biggest News Aggregation in the World

Page 24 - Solid Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solid Biosciences Today - Breaking & Trending Today

Analysts Anticipate Solid Biosciences Inc. (NASDAQ:SLDB) to Post -$0.21 EPS - Vimarsana News

Analysts Anticipate Solid Biosciences Inc. (NASDAQ:SLDB) to Post -$0.21 EPS

Published: May 7, 2022

Equities analysts predict that Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) will report earnings of ($0.21) per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Solid Biosciences’ earnings, with the lowest EPS estimate coming in at ($0.23) and the highest estimate coming in at ($0.17). Solid Biosciences […]

Source: etfdailynews.com
Related Topics:
United StatesZev SchneiderPiper SandlerRussell Investments Group LtdSecurities Exchange CommissionGoldman Sachs Group IncZacks Investment ResearchBlackrock IncParametric Portfolio AssociatesSolid Biosciences IncBarclays PlcSolid BiosciencesGet RatingSolid BioscienceInvestment ResearchChardan CapitalSolomon Zev SchneiderExchange CommissionInvestments GroupSachs GroupPortfolio AssociatesBiosciences IncNasdaq Sldb
Chutes & Ladders—Merck loses another top exec, this time to Moderna - Vimarsana News

Chutes & Ladders—Merck loses another top exec, this time to Moderna

Published: April 29, 2022

 Welcome to this week's Chutes & Ladders, our ro

Source: fiercebiotech.com
Related Topics:
Chutes And LaddersRonny GalBristol Myers SquibbNektar TherapeuticsSolid BiosciencesCaladrius BiosciencesBaxter InternationalGenerate BiomedicinesVedere BioJnana TherapeuticsY Mabs TherapeuticsIcahn School Of Medicine At Mount SinaiFlare TherapeuticsHomology MedicinesFierce Biotech Homepage
Solid Biosciences lays off 35% of workforce, chief operating officer exits - Vimarsana News

Solid Biosciences lays off 35% of workforce, chief operating officer exits

Published: April 27, 2022

Solid Biosciences is cutting over a third of its workforce—for the second time in two years.

Source: fiercebiotech.com
Related Topics:
Solid BiosciencesUchenne Muscular Dystrophy Dmd Gene TherapyChutes And LaddersFierce Biotech Homepage
Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce - Vimarsana News

Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce

Published: April 27, 2022

BioPharma

Source: biopharmadive.com
Related Topics:
Joel SchneiderDive BriefSolid BiosciencesChief Operating Officer Joel SchneiderGene Therapy
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial | Neurology | JAMA - Vimarsana News

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial | Neurology | JAMA

Published: April 5, 2022

This randomized clinical trial compares the efficacy and adverse effects of the 3 most frequently prescribed corticosteroid regimens for boys with Duchenne musc

Source: jamanetwork.com
Related Topics:
University Medical CenterUnited StatesGlasgow CityUnited KingdomCity OfVanderbilt UniversityNewcastle Upon TyneMedizinische FakultCraig CampbellIstituto Neurologico Carlo BestaTechnische UniversitMonika Krzesniak SwinarskaMatthew WicklundUlrike Schara SchmidtPerryb ShiehTanabe PharmaLos Angeles ShiehTaeun ChangNancyl KuntzViela BioCarl Gustav CarusAurora WicklundKevinm FlaniganHelen RoperJamesf Howard Jr